Knowledge Center

Presentation / Nov 05, 2014

Hovione Product Development & Licensing

Authors:
  • Courtney Smith
Source:
Bio Europe 2014, Courtney Smith

Hovione Product Development & Licensing

Also in the Knowledge Center

Related Content

Corticosteroids

Corticosteroids are produced in two dedicated buildings on the Loures site, which are equipped with vessels ranging from 50L up to 4000L.

Page
Read more

Drug Product Development

Leveraging our expertise particle engineering, Hovione can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

Inspections History

Hovione sites are periodically inspected by the local and external authorities. All sites are FDA approved and with exception of New Jersey site all have EU GMP certificates.

Page
Read more